Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Potential Inhibitors of Sars-Cov-2: Recent Advances Publisher Pubmed



Jamalipour Soufi G1 ; Iravani S2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Radiology Department, School of medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Faculty of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Journal of Drug Targeting Published:2021


Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) appeared in 2019 and is the causative agent of the new pandemic viral disease COVID-19. The outbreak of COVID-19 infection is affecting the entire world, thus many researchers and scientists are desperately looking for suitable vaccines and treatment options. Indeed, researches to find potential inhibitors of SARS-CoV-2 are mainly focussed on targeting virus-host interactions or inhibiting viral assembly. Additionally, drugs and other therapeutic agents that modulate broad-spectrum host innate immune responses or interfere with signalling pathways involved in viral replication are important. These drugs may be capable of engaging host receptors or proteases utilised for viral entry or may impact the endocytosis pathway. 3CLpro (3-chymotrypsin-like protease), PLpro (papain-like protease), RdRp (RNA-dependent RNA polymerase), S protein (viral spike glycoprotein), TMPRSS2 (transmembrane protease serine 2), ACE2 (angiotensin-converting enzyme 2), and AT2 (angiotensin AT2 receptor) are important targets. With no approved therapies, this pandemic illustrates the urgent need for safe and broad-spectrum antiviral agents and strategies against SARS-CoV-2 and future pathogenic viruses. In this review, we discussed about the recent trends and important challenges regarding the potential inhibitors, antiviral drugs and nanomaterials screened against SARS-CoV-2. © 2020 Informa UK Limited, trading as Taylor & Francis Group.
Related Docs
View other Related Docs
1. Sars-Cov-2 (Covid-19): New Discoveries and Current Challenges, Applied Sciences (Switzerland) (2020)
2. Drug Repositioning Approach to Target Viral and Host Cells in Terms of Covid-19 Treatment: A Review of in Vivo Experiments and Clinical Studies, Journal of Experimental and Clinical Medicine (Turkey) (2022)
3. Epidemiology, Virology, Clinical Features, Diagnosis, and Treatment of Sars-Cov-2 Infection, Journal of Experimental and Clinical Medicine (Turkey) (2021)
4. Emerging Technologies for the Treatment of Covid-19, Advances in Experimental Medicine and Biology (2021)
5. An Overview on the Genomic Characteristics of the New Coronavirus (2019-Ncov) and the Prospective in Pathogenesis and Treatment of Covid-19 Infection, Journal of Isfahan Medical School (2020)
6. Screening of Potential Inhibitors of Covid-19 With Repurposing Approach Via Molecular Docking, Network Modeling Analysis in Health Informatics and Bioinformatics (2022)
7. Nanobased Platforms for Diagnosis and Treatment of Covid-19: From Benchtop to Bedside, ACS Biomaterials Science and Engineering (2021)
8. Molecular Mechanisms Involved in Anosmia Induced by Sars-Cov-2, With a Focus on the Transmembrane Serine Protease Tmprss2, Archives of Virology (2022)
Experts (# of related papers)
View all Related Experts
Shaghayegh Haghjooy Javanmard (9)
Shahrzad Ahangarzadeh (8)
Other Related Docs
9. The Molecular Basis of Covid-19 Pathogenesis, Conventional and Nanomedicine Therapy, International Journal of Molecular Sciences (2021)
10. Corticosteroid Therapy for 2019 Novel Coronavirus: Lessons From Sars and Mers, Avicenna Journal of Clinical Microbiology and Infection (2021)
11. Potential Treatments for Covid-19; a Narrative Literature Review, Archives of Academic Emergency Medicine (2020)
12. An Updated Review of the Association of Host Genetic Factors With Susceptibility and Resistance to Covid-19, Journal of Cellular Physiology (2021)
13. Using in Silico Bioinformatics Algorithms for the Accurate Prediction of the Impact of Spike Protein Mutations on the Pathogenicity, Stability, and Functionality of the Sars-Cov-2 Virus and Analysis of Potential Therapeutic Targets, Biochemical Genetics (2023)
14. Sars-Cov-2, Sars and Mers: Three Formidable Coronaviruses Which Have Originated From Bats; [Sars-Cov-2, Sars-Cov I Mers-Cov: Trzy Grozne Koronawirusy Pochodzace Od Nietoperzy], Postepy Higieny i Medycyny Doswiadczalnej (2021)
15. Classification of Viral Proteins Expressed by the Sars-Cov-2 Genome, Acta Microbiologica Hellenica (2022)
16. A Comprehensive Review of Therapeutic Options for Covid-19, Ethiopian Journal of Health Development (2022)
17. A Narrative Literature Review on Traditional Medicine Options for Treatment of Corona Virus Disease 2019 (Covid-19), Complementary Therapies in Clinical Practice (2020)
18. The Effect of Various Compounds on the Covid Mechanisms, From Chemical to Molecular Aspects, Biophysical Chemistry (2022)
19. Nanostructures for Prevention, Diagnosis, and Treatment of Viral Respiratory Infections: From Influenza Virus to Sars-Cov-2 Variants, Journal of Nanobiotechnology (2023)
20. Epigenetic Regulation of Autophagy in Coronavirus Disease 2019 (Covid-19), Biochemistry and Biophysics Reports (2022)
21. Novel and Emerging Mutations of Sars-Cov-2: Biomedical Implications, Biomedicine and Pharmacotherapy (2021)
22. Immune and Bioinformatics Identification of T Cell and B Cell Epitopes in the Protein Structure of Sars-Cov-2: A Systematic Review, International Immunopharmacology (2020)
23. Cancer Care Management During the Covid-19 Pandemic, Risk Management and Healthcare Policy (2020)
24. Nervous System Involvement in Covid-19: A Review of the Current Knowledge, Molecular Neurobiology (2021)
25. In Silico Investigation of Critical Binding Pattern in Sars-Cov-2 Spike Protein With Angiotensin-Converting Enzyme 2, Scientific Reports (2021)
26. The Role of Immune Regulatory Molecules in Covid-19, Viral Immunology (2022)
27. Medicinal Chemistry of Antisense Oligonucleotides for Therapeutic Use in Sars-Cov-2: Design Strategies and Challenges for Targeted Delivery, Current medicinal chemistry (2025)
28. Vaccine Production by Recognizing the Functional Mechanisms of Covid-19, Translational Research in Urology (2020)
29. A Review of Novel Coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2), Iranian Journal of Medical Microbiology (2020)
30. Covid-19 Pandemic: Insights Into Genetic Susceptibility to Sars-Cov-2 and Host Genes Implications on Virus Spread, Disease Severity and Outcomes, Human Antibodies (2022)
31. Quantum Dots Against Sars-Cov-2: Diagnostic and Therapeutic Potentials, Journal of Chemical Technology and Biotechnology (2022)
32. Therapeutic Targets of Natural Products for the Management of Cardiovascular Symptoms of Coronavirus Disease 2019, Phytotherapy Research (2021)
33. Herbal Medicines As Potential Inhibitors of Sars-Cov-2 Infection, Current Pharmaceutical Design (2022)
34. Cardiovascular Complications of Sars-Cov-2 Vaccines: An Overview, Cardiology and Therapy (2022)
35. Computational Design of a Potential Therapeutic Peptide Against Spike Protein of Sars-Cov-2, Journal of Computational Biophysics and Chemistry (2021)
36. Nanosponges: An Overlooked Promising Strategy to Combat Sars-Cov-2, Drug Discovery Today (2022)
37. Pi3k/Akt/Mtor Pathway: A Potential Target for Anti-Sars-Cov-2 Therapy, Immunologic Research (2022)
38. Novel Sars-Cov2 Poly Epitope Phage-Based Candidate Vaccine and Its Immunogenicity, Research in Pharmaceutical Sciences (2024)
39. Current Status of Covid-19 Pandemic; Characteristics, Diagnosis, Prevention, and Treatment, Journal of Research in Medical Sciences (2020)
40. Covid-19 and the Potential of Janus Family Kinase (Jak) Pathway Inhibition: A Novel Treatment Strategy, Frontiers in Medicine (2022)
41. The Role of Serum Circulating Microbial Toxins in Severity and Cytokine Storm of Covid Positive Patients, Microbial Pathogenesis (2023)
42. Nanomaterials and Nanotechnology-Associated Innovations Against Viral Infections With a Focus on Coronaviruses, Nanomaterials (2020)
43. Selective Serotonin Reuptake Inhibitors: New Hope in the Fight Against Covid-19, Frontiers in Pharmacology (2022)
44. A Comprehensive Review on Potentially Therapeutic Agents Against Covid-19 From Natural Sources, Current Traditional Medicine (2024)
45. Nanomaterials Against Pathogenic Viruses: Greener and Sustainable Approaches, Inorganic and Nano-Metal Chemistry (2020)
46. Antiviral Mechanisms of Curcumin and Its Derivatives in Prevention and Treatment of Covid-19: A Review, Advances in Experimental Medicine and Biology (2023)
47. Towards Screening and Repurposing of Approved Drugs for the Treatment of Covid-19 Using Molecular Docking, Physical Chemistry Research (2023)
48. A Narrative Review of Covid-19: The New Pandemic Disease, Iranian Journal of Medical Sciences (2020)
49. Important Roles of Oligo-And Polysaccharides Against Sars-Cov-2: Recent Advances, Applied Sciences (Switzerland) (2021)
50. Thrombotic Storm in Coronavirus Disease 2019: From Underlying Mechanisms to Its Management, Journal of Medical Microbiology (2022)